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Influenza (Flu) is an infectious disease caused by negative-single-stranded and segmented
RNA viruses, which belong to the Orthomyxoviridae family. These are classified in type A, 
B, C and D. Among them, influenza A virus (FluA) is responsible for the most important
human pandemics of the last century and it is very difficult to prevent and to treat because of 
the high mutation rate and genomic reassortment. The RNA-dependent RNA polymerase 
(RdRp) is widely recognized as one of the more promising anti-flu target, since it has a 
critical role in FluA infection progression and possesses a high genomic sequence 
conservation. RdRp is constituted by three subunit: PA (polymerase acid protein), PB1 and 
PB2 (polymerase basic protein 1 and 2) [1]. Our group has already identified the 3-cyano-4,6-
diphenyl-pyridine scaffold 1 (Figure) as an interesting disruptor of the PA-PB1 complex of
RdRp, by mimicking the N-terminal portion of PB1 and the most important interactions with 
the C-terminal domain of PA [2,3]. Starting from this background, we decided to explore the 
chemical space around the C2 side chain of the pyridine scaffold, synthesizing derivatives 2a-
p (Figure). We introduced in C2 one, two or three amino acids as free acids or as esters, to
ensure membrane permeability. The majority of the molecules are not cytotoxic (CC50 values 
>250 μM) and some of them show a good antiviral activity. In particular, the most active 
derivative possesses an IC50 of 36 μM and EC50 values of 39 μM and 53 μM in plaque 
reduction assay (PRA) and in minireplicon assay, respectively. Detailed biological data will 
be reported in the poster section.
Figure: General structures of first (1) and second (2) generations of 3-cyano-4,6-diphenyl-pyridine derivatives
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